ES2082013T3 - Antagonistas de receptores muscarinicos. - Google Patents

Antagonistas de receptores muscarinicos.

Info

Publication number
ES2082013T3
ES2082013T3 ES90917074T ES90917074T ES2082013T3 ES 2082013 T3 ES2082013 T3 ES 2082013T3 ES 90917074 T ES90917074 T ES 90917074T ES 90917074 T ES90917074 T ES 90917074T ES 2082013 T3 ES2082013 T3 ES 2082013T3
Authority
ES
Spain
Prior art keywords
alkyl
independently
receptor antagonists
muscarinic receptor
muscarinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90917074T
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Peter Edward Cross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2082013T3 publication Critical patent/ES2082013T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ANTAGONISTAS RECEPTORES MUSCARINICOS. UN ANTAGONISTAS RECEPTORES MUSCARINICOS CON LA FORMULA O UNA SAL FARMACEUTICAMENTE ACEPTABLE, EN DONDE Y ES UN ENLACE DIRECTO, -CH2-, -(CH2)2-, -CH2O LAS FORMULAS, O HET EN DONDE R2 Y R3 SON CADA UNO INDEPENDIENTEMENTE H, C1-C4 ALQUILO, C1-C4 ALCOXI, -(CH2)NOH, HALO, TRIFLUOROMETILO, CIANO, -(CH2)NNR4R5, -CO(C1-C4 ALQUILO), -OCO(C1-C4 ALQUILO), -CH(OH)(C1-C4 ALQUILO), -C(OH)(C1-C4 ALQUILO)2, -SO2NH2, -(CH2)NCONR5R6 O -(CH2)NCOO(C1-C4 ALQUILO); R4 Y R5 SON INDEPENDIENTEMENTE H O C1-C4 ALQUILO; N ES 0, 1 O 2; X Y X1 SON CADA UNO INDEPENDIENTEMENTE O O CH2; M ES 1, 2 O 3; Y "HET" ES PIRIDILO, PIRACINILO O TIENILO. LOS COMPUESTOS SON PARTICULARMENTE UTILES EN EL TRATAMIENTO DEL SINDROME DE INTESTINO IRRITABLE.
ES90917074T 1989-12-12 1990-11-28 Antagonistas de receptores muscarinicos. Expired - Lifetime ES2082013T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928041A GB8928041D0 (en) 1989-12-12 1989-12-12 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
ES2082013T3 true ES2082013T3 (es) 1996-03-16

Family

ID=10667812

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90917074T Expired - Lifetime ES2082013T3 (es) 1989-12-12 1990-11-28 Antagonistas de receptores muscarinicos.

Country Status (14)

Country Link
US (1) US5281601A (es)
EP (1) EP0505377B1 (es)
JP (1) JPH0684370B2 (es)
AT (1) ATE132488T1 (es)
CA (1) CA2067816C (es)
DE (1) DE69024663T2 (es)
DK (1) DK0505377T3 (es)
ES (1) ES2082013T3 (es)
FI (1) FI104719B (es)
GB (1) GB8928041D0 (es)
GR (1) GR3019036T3 (es)
IE (1) IE70733B1 (es)
PT (1) PT96143B (es)
WO (1) WO1991009015A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
US6906072B1 (en) * 2000-01-20 2005-06-14 Eisai Co., Ltd. Piperazine compound and pharmaceutical composition containing the compound
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
HK1079787A1 (zh) * 2002-07-31 2006-04-13 Ranbaxy Laboratories Limited 用作毒蕈碱受体拮抗剂的3，6-二取代的氮杂双环[3．1．0]己烷衍生物
WO2004014363A1 (en) * 2002-08-09 2004-02-19 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
EP1534675B1 (en) * 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
TWI295669B (en) * 2002-10-30 2008-04-11 Theravance Inc Substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
ATE400553T1 (de) * 2002-12-10 2008-07-15 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo 3.1.0 - hexanderivative als antagonisten des muscarinrezeptors
DE60225195T2 (de) * 2002-12-23 2009-02-26 Ranbaxy Laboratories, Ltd. Flavaxat-derivate als muscarin-rezeptor antagonisten
AU2002347552A1 (en) * 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1618091A1 (en) * 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2003223010A1 (en) 2003-04-10 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EA009059B1 (ru) * 2003-04-10 2007-10-26 Рэнбакси Лабораториз Лимитед Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
JP2006522787A (ja) * 2003-04-11 2006-10-05 ランバクシー ラボラトリーズ リミテッド ムスカリン様受容体アンタゴニストとしてのアザビシクロ誘導体
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
US7234991B2 (en) * 2004-05-10 2007-06-26 Firecode Ltd. Moving toy
WO2006005980A1 (en) * 2004-06-16 2006-01-19 Ranbaxy Laboratories Limited Xanthine derivatives useful as muscarinic receptor antagonists
US20080262075A1 (en) * 2004-08-19 2008-10-23 Ranbaxy Laboratories Limited Pyrrolidine Derivatives as Muscarinic Receptor Antagonists
WO2006032994A2 (en) * 2004-09-24 2006-03-30 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
EP1797040A1 (en) * 2004-09-29 2007-06-20 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
EP1828126A1 (en) * 2004-12-15 2007-09-05 Ranbaxy Laboratories Limited Acid addition salts of muscarinic receptor antagonists
WO2006117754A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632403A (es) * 1962-05-17 1900-01-01
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
ATE132488T1 (de) 1996-01-15
FI922344L (fi) 1992-05-22
GB8928041D0 (en) 1990-02-14
PT96143A (pt) 1991-09-30
FI104719B (fi) 2000-03-31
JPH05501555A (ja) 1993-03-25
US5281601A (en) 1994-01-25
FI922344A0 (fi) 1992-05-22
JPH0684370B2 (ja) 1994-10-26
IE904462A1 (en) 1991-06-19
DE69024663D1 (de) 1996-02-15
CA2067816A1 (en) 1991-06-13
IE70733B1 (en) 1996-12-11
DE69024663T2 (de) 1996-05-15
WO1991009015A1 (en) 1991-06-27
EP0505377A1 (en) 1992-09-30
DK0505377T3 (da) 1996-02-05
CA2067816C (en) 1997-03-25
EP0505377B1 (en) 1996-01-03
GR3019036T3 (en) 1996-05-31
PT96143B (pt) 1997-05-28

Similar Documents

Publication Publication Date Title
ES2082013T3 (es) Antagonistas de receptores muscarinicos.
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
ES2060020T3 (es) Derivados de pirrolidina.
ATE188472T1 (de) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
DK0593478T3 (da) Leukotrien-B4-antagonister
ES2110260T3 (es) Androstenonas.
ES2078356T3 (es) Derivados de la pirrolidina y de la piperidina.
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
ES2063381T3 (es) Antagonistas de los receptores muscarinicos.
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
GR3002140T3 (en) Muscarinic receptor antagonists
ES2057601T3 (es) Antagonistas de receptores muscarinicos.
ES2102353T3 (es) Antagonistas del receptor muscarinico.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
ATE101599T1 (de) Muscarin-rezeptor-antagonisten.
ATE114310T1 (de) Alpha-adrenergische rezeptorantagonisten.
DE68917217D1 (de) Alpha-adrenergische Rezeptorantagonisten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 505377

Country of ref document: ES